EMEA-001830-PIP01-15-M01

Key facts

Invented name
  • Foclivia
  • Foclivia and associated names
Active substance
Pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)
Therapeutic area
Vaccines
Decision number
P/0260/2018
PIP number
EMEA-001830-PIP01-15-M01
Pharmaceutical form(s)
Suspension for injection
Condition(s) / indication(s)
Prevention of influenza infection
Route(s) of administration
Intramuscular use
Contact for public enquiries
Seqirus S.r.l.

E-mail: pip.seq@seqirus.com
Tel. + 39 0577 096400

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating